Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

Add To Watchlist

Bullboard (TSX:ONC)

View:

Comment by Noteableon Nov 23, 2024 4:32pm

RE:RE:RE:RE:CAR-T update

November 21, 2024 - “Unlike synthetic cancer drugs that we put into a patient, which have virtually all been developed in the last 100 years, the immune system has evolved since long before ...more

Discussion

Comment by Noteableon Nov 23, 2024 2:54pm

RE:RE:RE:CAR-T update

November 21, 2024 - Novartis is betting on direct cellular engineering through a collaboration with [oncolytic virus company] Vyriad, the companies announced Wednesday. “As an industry pioneer in the ...more

Discussion

Level Up Your Trading with BMO InvestorLine’s Enhanced Features

posted Nov 23, 2024 9:00am by Bank of Montreal

Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more

Comment by Buckhenryon Nov 23, 2024 1:57pm

RE:RE:RE:RE:RE:My thanks , philosophical thoughts

If you read about car-t in general you will see that there are only a handful of fda approvals and the fda has a warning about using car-t. The industry is skiddish about jumping into this ...more

Discussion

Comment by Noteableon Nov 23, 2024 1:39pm

RE:RE:RE:Biotech industry readies for " Pharma M&A Spree"

November 19, 2024 - For “almost three years now” deal making has been a challenge across the life sciences industry, said Ed Saltman, senior strategic advisor at consultancy firm Lumanity, described ...more

Discussion

Comment by Noteableon Nov 23, 2024 11:10am

RE:RE:Biotech industry readies for " Pharma M&A Spree"

The recent push to plug patent-loss gaps by Big Pharma has left fewer late-stage biotechs available for Big Pharma to scoop up, so there are more deals around earlier-stage companies and assets. The ...more

Discussion

Comment by Noteableon Nov 23, 2024 10:49am

RE:RE:RE:RE:RE:How does Accelerated Approval work

With Replimmune leading the way on Accelerated Approval (AA) and the FDA granting Replimmune's intratumorally (IT) delivered OV therapy Breakthrough Therapy Designation (BTD), ONCY's ...more

Discussion

Comment by venture009on Nov 23, 2024 10:36am

RE:RE:RE:RE:My thanks , philosophical thoughts

Quentin, I think March is too long a time frame. The economics of the US and global economies are in dire straits. It is going to get more and more difficult to get companies to part with their money ...more

Discussion

Comment by Noteableon Nov 22, 2024 6:42pm

RE:RE:RE:RE:How does Accelerated Approval work

As antibody-drug conjugates (ADCs) grow their importance in the oncology treatment space, efforts are underway to combine them with other agents, such as immune checkpoint inhibitors. That being said, ...more

Discussion

Comment by m00nsh0tson Nov 22, 2024 6:02pm

RE:RE:RE:How does Accelerated Approval work

Merck also collaborating with PYXIS' ADC in the biologic area.

Discussion

Comment by Noteableon Nov 22, 2024 6:01pm

RE:RE:Biotech industry readies for " Pharma M&A Spree"

Furthermore, a Republican administration may be friendlier to large deals and may focus its drug pricing bite on PBMs rather than on pharma's deal-making activities.

Discussion

Comment by Noteableon Nov 22, 2024 5:55pm

RE:Biotech industry readies for " Pharma M&A Spree"

So what does that mean? The push to plug patent-loss gaps has left fewer late-stage biotechs available for Big Pharma to scoop up, so there are more deals around earlier-stage companies and assets ...more

Discussion

Post by Noteableon Nov 22, 2024 5:26pm

Biotech industry readies for " Pharma M&A Spree"

November 16, 2024 - "Biotechnology and big pharma are noteworthy. Pharma needs biotech for new products, so M&A benefits both—securing revenue for pharma and providing premium buyouts for ...more

113

Discussion

Comment by Noteableon Nov 22, 2024 5:10pm

RE:RE:RE:RE:“Second mouse gets the cheese “

With Replimmune leading the way on Accelerated Approval (AA) and the FDA granting Replimmune's intratumorally (IT) delivered OV therapy Breakthrough Therapy Designation (BTD), ONCY's ...more

Discussion

Comment by Noteableon Nov 22, 2024 4:52pm

RE:RE:RE:RE:How does Accelerated Approval work

Fast Track and Acceleratred Approval Pathways: The FDA Modernization Act of 1997 established the Fast Track designation to expedite developing and reviewing new drugs designed to fill unmet medical ...more

Discussion

Comment by Noteableon Nov 22, 2024 4:40pm

RE:RE:RE:How does Accelerated Approval work

With Merck now throwing its hat into the ring, investors can rest assured that the business development teams of Bristol Myers Squibb, Roche, Sanofi, BMS, AstraZeneca and others are seeking out their ...more

Discussion

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (TSX:ONC)